Federal judge approves bankruptcy settlement for Purdue Pharma

Conditional settlement reached with Purdue over opioid crisis in US

A US federal bankruptcy judge gave conditional approval to a settlement that will remove the Sackler family from ownership of OxyContin maker Purdue Pharma and devote potentially 10 billion US dollars to fighting the opioid crisis that has killed half a million Americans over the past two decades.

US judge approves deal dissolving Purdue Pharma in opioid saga

Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the US opioid crisis, will be dissolved under a plan approved by a federal judge on Wednesday.

US judge approves $4.5bn ‘opioid crisis’ settlement to dissolve OxyContin maker Purdue Pharma… and grant Sackler family IMMUNITY

Purdue Pharma, the maker of the powerful opioid OxyContin, will be dissolved after a federal judge approved a $4.5 billion settlement deal with the firm’s owners, who will be granted immunity from future lawsuits in exchange.

Judge conditionally approves plan to dissolve OxyContin maker Purdue Pharma

Judge Robert Drain called this a "bitter" end and said he wished claimants were getting more money in the settlement deal.

Judge conditionally approves plan to dissolve OxyContin maker Purdue Pharma

Judge Robert Drain called this a "bitter" end and said he wished claimants were getting more money in the settlement deal.

Judge conditionally approves plan to dissolve OxyContin maker Purdue Pharma

Judge Robert Drain called this a "bitter" end and said he wished claimants were getting more money in the settlement deal.